An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model
作者:Daniel J. Price、David H. Drewry、Lee T. Schaller、Brian D. Thompson、Paul R. Reid、Patrick R. Maloney、Xi Liang、Periette Banker、Richard G. Buckholz、Paula K. Selley、Octerloney B. McDonald、Jeffery L. Smith、Todd W. Shearer、Richard F. Cox、Shawn P. Williams、Robert A. Reid、Stefano Tacconi、Federico Faggioni、Chiara Piubelli、Ilaria Sartori、Michela Tessari、Tony Y. Wang
DOI:10.1016/j.bmcl.2018.03.034
日期:2018.6
Hypothalamic CAMKK2 represents a potential mechanism for chemically affecting satiety and promoting weight loss in clinically obese patients. Single-digit nanomolar inhibitors of CAMKK2 were identified in three related ATP-competitive series. Limited optimization of kinase selectivity, solubility, and pharmacokinetic properties were undertaken on all three series, as SAR was often transferrable. Ultimately